Today: 13 May 2026
Gold Price Today Slips as Dollar, Oil Shock Put $5,000 Forecast in Doubt
20 April 2026
2 mins read

Gold Price Today Slips as Dollar, Oil Shock Put $5,000 Forecast in Doubt

NEW YORK, April 20, 2026, 10:43 EDT

  • Gold slipped to its lowest in a week, pressured by gains in the dollar and higher U.S. yields.
  • Gold lost some safe-haven appeal as oil surged on new U.S.-Iran tensions.
  • Analysts flagged $5,000 as the immediate hurdle bulls have to clear.

Gold slipped Monday, with spot prices hitting a one-week low as strength in the dollar and a bump in oil prices took the shine off bullion. By 9:23 a.m. EDT, spot gold had dropped 0.3% to $4,818.03 an ounce. June U.S. gold futures lost 0.8%, settling at $4,839.10.

Gold usually finds buyers during geopolitical flare-ups, but inflation is tugging prices lower this time. U.S.-Iran tensions have lifted oil roughly 5%, stoking worries that higher energy prices may keep inflation stubborn and rates elevated.

Gold tends to struggle when rates climb, since it doesn’t offer interest. Rising Treasury yields tilt the scales toward bonds, while a firmer dollar pushes up the price of bullion for buyers outside the U.S.

Reuters reported that pressure ratcheted up after the U.S. seized an Iranian cargo ship and Tehran threatened to hit back, shaking confidence in a ceasefire. As a result, most movement through the Strait of Hormuz stayed frozen.

Fawad Razaqzada, a market analyst with City Index and FOREX.com, flagged the Middle East situation as a reason he’s turned “slightly to the downside” on gold. He pointed to the chance of another oil spike, warning it could push the dollar and bond yields higher. Reuters

Eyes now shift to the $5,000 mark in the near-term outlook. Jim Wyckoff, senior analyst at Kitco Metals, noted June gold bulls are looking for a close above that threshold. On the flip side, traders have cited “bearish daily elements”—the dollar and yields among them. Reuters

Han Tan, chief market analyst at Bybit, pointed out that oil’s jump has pushed “inflation risks” front and center, with gold now “taking a backseat” as traders favor the dollar for safety. According to Tan, spot gold looks set to trade below $5,000, barring any significant and lasting de-escalation. kitco.com

Yet the outlook for gold remains mixed. “Structural demand drivers persist,” said Nikos Tzabouras, senior market analyst at Jefferies-owned Tradu.com, highlighting ongoing central-bank purchases, concerns about de-dollarisation, and worries over currency debasement as key factors keeping bullion supported. kitco.com

Traders kept up the momentum. At 10:00 a.m. in New York, AP reported open interest in COMEX gold futures reaching 360,881 contracts, a jump of 14,538 from the last tally. Estimated volume came in at 89,375 contracts. COMEX handles most U.S. gold futures, with each contract representing 100 troy ounces.

Silver tracked gold lower, dropping 0.8% to $80.18 per ounce. Platinum retreated 1.2% to $2,077.35, while palladium edged down 0.3% to $1,554.48—both platinum and palladium briefly hit their lowest in a week.

Neither bulls nor bears have an easy setup here. A sharper oil shock might hold up the dollar and yields, keeping gold stuck under $5,000, even with higher geopolitical risk. On the flip side, if U.S.-Iran tensions cool off or U.S. yields slip, that could clear the way for buyers to push gold back toward that $5,000 mark.

At this point, gold is behaving more like an inflation play than a pure safe haven. The short-term outlook hinges less on nerves, more on whether oil, the dollar, and Treasury yields keep pushing the same way.

Stock Market Today

  • Pfizer Set to Outperform Market Over Next 5 Years Driven by New Products and Pipeline
    May 12, 2026, 8:48 PM EDT. Pfizer's (PFE) stock, down 35% over five years, is poised for a turnaround as new medicines like Abrysvo (RSV vaccine) and cancer drugs Elrexfio and Padcev show strong sales growth. Despite patent expirations weighing on older products such as Eliquis, Pfizer trades at a low forward price-to-earnings ratio of 8.8x versus 16.8x for healthcare peers, indicating market skepticism may be overdone. The company projects launching around 20 pivotal studies in 2026, including promising weight-loss drugs like MET-097i. Pfizer's strategic focus on expanding and innovating its drug pipeline suggests potential for sustained revenue growth and long-term stock appreciation through 2031.

Latest article

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

US Stocks Lose Their Record Edge After Hours as Oil Turns Inflation Into a Fed Problem

13 May 2026
Tech stocks led declines Tuesday after April CPI data showed consumer prices rose 0.6% for the month and 3.8% year-over-year, pushing Treasury yields higher and weighing on rate-cut hopes. Brent crude settled above $107, fueling inflation concerns. The S&P 500 slipped 11.88 points to 7,400.96, while the Nasdaq lost 185.92 to 26,088.20. Chip stocks fell sharply, with Qualcomm down 11% and Intel off 6.8%.
Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

Karman Stock’s Rally Turns Into an Earnings Test as Backlog Jumps and Valuation Bites

13 May 2026
Karman Holdings shares closed up 6.2% at $62.48 on May 12, then fell 11% after hours following first-quarter results and a raised 2026 outlook. Q1 revenue jumped 51% to $151.2 million, net income reached $7.8 million, and backlog hit $1.0 billion. Adjusted EPS matched the $0.11 estimate. The company announced over $1 billion in new contingent demand commitments.
Velo3D Stock Jumps After Q1 Results Turn Margin Story Into a Real Test

Velo3D Stock Jumps After Q1 Results Turn Margin Story Into a Real Test

13 May 2026
Velo3D shares surged 24.7% to $17.53 in after-hours trading Tuesday after first-quarter revenue rose 48% to $13.8 million and net loss narrowed to $7.0 million. Gross margin improved to 17.2%. The company raised $50 million in April but remains loss-making, with a recent going-concern warning. Backlog stood near $30 million, with repeat orders above 70% of total.
Boeing Pushes Chinook Drone-Swarm Vision as Commercial Jet Recovery Faces Earnings Test
Previous Story

Boeing Pushes Chinook Drone-Swarm Vision as Commercial Jet Recovery Faces Earnings Test

Broadcom Nears $2 Trillion on Software, AI Chip Boom as Google-Marvell Talks Raise Risk
Next Story

Broadcom Nears $2 Trillion on Software, AI Chip Boom as Google-Marvell Talks Raise Risk

Go toTop